1.Alternative Name:FOLH1
2.Target:PSMA
3.Source:Human PSMA was expressed from HEK293 with human IgG1 FC at the N-terminal
4.Sequence:Lys44-Ala750
5.Protein structure:hFCQ04609
6.Molecular Characterization:The protein has a calculated MW of 105kDa.The reducing (R) heterodimer protein migrates as 120-150 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA
    
When Recombinant Human PSMA/hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human PMSA（Rosopatamab）that produces 50% of the optimal binding response is approximately 50 ng/ml.
Note:For research use only .